Factor X binders enhancing FX activation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11787874
APP PUB NO 20210054097A1
SERIAL NO

16764124

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The application relates to unique FX binding molecules, such as antibodies and fragments thereof which are useful in the treatment of haemophilia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK A/SNOVO ALLE BAGSVAERD DK-2880

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buyse, Marie-Ange Merelbeke, BE 88 468
De, Tavernier Evelyn Deurle, BE 14 89
Harndahl, Mikkel Nors Roskilde, DK 5 1
Lund, Jacob Roskilde, DK 3 0
Steffensen, Soren Etterbeek, BE 34 174
Thorn, Karina Farum, DK 7 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 17, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 17, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 17, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00